Published Date：Nov. 2020
Industry：Medical Devices & Consumables
Pages：113 Table Number：135
Single User Price：￥3650.00
Enterprise User Price：￥5600.00
Summary As the world continues to deal with COVID-19, economies are moving into recession, under multiple adverse factors, the GDP of European and American countries in the second quarter suffered a historical contraction. At an annualized rate, the US GDP fell by 32.9% month on month, while the overall GDP of the euro zone fell by 12.1%. Moreover, the economic prospects of Europe and the United States in the third quarter under the epidemic situation are hardly optimistic. The resumption of work and production not only brought economic data back, but also triggered a rebound in the epidemic situation. At present, the United States is still the 'epicenter' of the global epidemic. The total number of confirmed cases has exceeded 4.8 million, and the epidemic situation in some European countries has also rebounded. Affected by this, more than 20 states in the United States have announced the suspension or withdrawal of part of the economic restart plan. Britain and Italy have also decided to extend the state of emergency. The rebound of the epidemic situation has posed considerable risks to the economic prospects of Europe and the United States. In the second quarter of this year, US GDP shrank by 9.5% on a month on month basis, or 32.9% at an annual rate, the largest decline since the 1940s. Data show that the sharp decline in personal consumption is the main drag on the U.S. GDP growth in the second quarter. Compared with the United States, Europe's economic contraction in the second quarter was smaller, but it was also the lowest on record, with Germany and France contracting more than 10%. According to the data released by the Federal Bureau of statistics, Germany's GDP fell by 10.1% in the second quarter after adjusting for prices, seasons and working days, the largest decline since the quarterly economic data were available in 1970. Thanks to the effective control and policy support of the new epidemic, China's economy rebounded sharply in the second quarter. The growth rate of manufacturing industry, which accounted for about 28% of GDP, rebounded sharply to 4.4% from the negative value in the first quarter. Chinese original equipment manufacturers (OEMs) and suppliers are ramping up production. And there are increased investments in digital footprints in manufacturing. OEMs in other parts of the world are offering incentives to drive sales. XYZResearch published a report for global Monoclonal Antibody Therapeutics market in this environment. In terms of revenue, this research report indicated that the global Monoclonal Antibody Therapeutics market was valued at USD XXX million in 2019, and it is expected to reach a value of USD XXX million by 2026, at a CAGR of XX % over the forecast period 2021-2026. Correspondingly, the forecast analysis of Monoclonal Antibody Therapeutics industry comprises of China, USA, Japan, India, Korea and South America, with the production and revenue data in each of the sub-segments. The ????Bayer aims at producing XX Monoclonal Antibody Therapeutics in 2020, with XX % production to take place in global market, ????F. Hoffmann-La Roche accounts for a volume share of XX %. Regional Segmentation (Value; Revenue, USD Million, 2015 - 2026) of Monoclonal Antibody Therapeutics Market by XYZResearch Include China EU USA Japan India Southeast Asia South America Competitive Analysis; Who are the Major Players in Monoclonal Antibody Therapeutics Market? Bayer F. Hoffmann-La Roche Pfizer Sanofi GlaxoSmithKline Merck Novartis AbbVie Amgen Johnson & Johnson Bristol-Myers Squibb Company Biogen ... Major Type of Monoclonal Antibody Therapeutics Covered in XYZResearch report: Humanized Antibody Human Mouse Chimeric Antibody Application Segments Covered in XYZResearch Market Cancer Autoimmune Diseases Infection Hematological Diseases Ophthalmological Diseases Others For any other requirements, please feel free to contact us and we will provide you customized report.
Table of Contents Global Monoclonal Antibody Therapeutics Market Analysis 2020, With Top Companies, Production, Revenue, Consumption, Price and Growth Rate 1 Market Scope 1.1 Product Details and Introduction 1.1.1 Humanized Antibody -Product Introduction and Major Manufacturers 1.1.2 Human Mouse Chimeric Antibody -Product Introduction and Major Manufacturers 1.2 Market Snapshot 1.2.1 Major Companies Overview 1.2.2 Market Concentration 1.2.3 Six-Year Compound Annual Growth Rate (CAGR) 2 Global Monoclonal Antibody Therapeutics Market Assessment, by Segmentation 2.1 Type Breakdown Estimates & Forecast, Sales Volume (2015-2026) 2.2 Type Breakdown Estimates & Forecast, Sales Value (2015-2026) 2.3 Application Breakdown Estimates & Forecast, by Application (2015-2026) 3 Regional Market Analysis 3.1 China Monoclonal Antibody Therapeutics Market 3.1.1 Top Companies leading Monoclonal Antibody Therapeutics Development in China (2015-2020) 3.1.2 Sales Value of Major Company in China Market (2015-2020) 3.1.3 China Monoclonal Antibody Therapeutics Price (USD/Unit), by Type (2019-2020) 3.1.4 Sales in China Market, by Type (2015-2026) 3.2 EU Monoclonal Antibody Therapeutics Market 3.2.1 Top Companies leading Monoclonal Antibody Therapeutics Development in EU (2015-2020) 3.2.2 Sales Value of Major Company in EU Market (2015-2020) 3.2.3 EU Monoclonal Antibody Therapeutics Price (USD/Unit), by Type (2019-2020) 3.2.4 Sales in EU Market, by Type (2015-2026) 3.3 USA Monoclonal Antibody Therapeutics Market 3.3.1 Top Companies leading Monoclonal Antibody Therapeutics Development in USA (2015-2020) 3.3.2 Sales Value of Major Company in USA Market (2015-2020) 3.3.3 USA Monoclonal Antibody Therapeutics Price (USD/Unit), by Type (2019-2020) 3.3.4 Sales in USA Market, by Type (2015-2026) 3.4 Japan Monoclonal Antibody Therapeutics Market 3.4.1 Top Companies leading Monoclonal Antibody Therapeutics Development in Japan (2015-2020) 3.4.2 Sales Value of Major Company in Japan Market (2015-2020) 3.4.3 Japan Monoclonal Antibody Therapeutics Price (USD/Unit), by Type (2019-2020) 3.4.4 Sales in Japan Market, by Type (2015-2026) 3.5 India Monoclonal Antibody Therapeutics Market 3.5.1 Top Companies leading Monoclonal Antibody Therapeutics Development in India (2015-2020) 3.5.2 Sales Value of Major Company in India Market (2015-2020) 3.5.3 India Monoclonal Antibody Therapeutics Price (USD/Unit), by Type (2019-2020) 3.5.4 Sales in India Market, by Type (2015-2026) 3.6 Southeast Asia Monoclonal Antibody Therapeutics Market 3.6.1 Top Companies leading Monoclonal Antibody Therapeutics Development in Southeast Asia (2015-2020) 3.6.2 Sales Value of Major Company in Southeast Asia Market (2015-2020) 3.6.3 Southeast Asia Monoclonal Antibody Therapeutics Price (USD/Unit), by Type (2019-2020) 3.6.4 Sales in Southeast Asia Market, by Type (2015-2026) 3.7 South America Monoclonal Antibody Therapeutics Market 3.7.1 Top Companies leading Monoclonal Antibody Therapeutics Development in South America (2015-2020) 3.7.2 Sales Value of Major Company in South America Market (2015-2020) 3.7.3 South America Monoclonal Antibody Therapeutics Price (USD/Unit), by Type (2019-2020) 3.7.4 Sales in South America Market, by Type (2015-2026) 4 Value Chain (Impact of COVID-19) 4.1 Monoclonal Antibody Therapeutics Value Chain Analysis 4.1.1 Upstream 4.1.2 Downstream 4.2 COVID-19 Impact on Monoclonal Antibody Therapeutics Industry 4.2.1 Industrial Policy Issued Under the Epidemic Situation 4.3 Cost-Under the Epidemic Situation 4.3.1 Cost of Raw Material 4.4 Channel Analysis 4.4.1 Distribution Channel-Under the Epidemic Situation 4.4.2 Distributors 5 Regional Market Forecast (2021-2026) 5.1 Global Monoclonal Antibody Therapeutics Sales and Growth Rate (2021-2026) 5.2 Global Monoclonal Antibody Therapeutics Sales Value and Growth Rate (2021-2026) 6 Monoclonal Antibody Therapeutics Competitive Analysis 6.1 Bayer 6.1.1 Bayer Company Profiles 6.1.2 Bayer Product Introduction 6.1.3 Bayer Monoclonal Antibody Therapeutics Production, Revenue (2015-2020) 6.1.4 SWOT Analysis 6.2 F. Hoffmann-La Roche 6.2.1 F. Hoffmann-La Roche Company Profiles 6.2.2 F. Hoffmann-La Roche Product Introduction 6.2.3 F. Hoffmann-La Roche Monoclonal Antibody Therapeutics Production, Revenue (2015-2020) 6.2.4 SWOT Analysis 6.3 Pfizer 6.3.1 Pfizer Company Profiles 6.3.2 Pfizer Product Introduction 6.3.3 Pfizer Monoclonal Antibody Therapeutics Production, Revenue (2015-2020) 6.3.4 SWOT Analysis 6.4 Sanofi 6.4.1 Sanofi Company Profiles 6.4.2 Sanofi Product Introduction 6.4.3 Sanofi Monoclonal Antibody Therapeutics Production, Revenue (2015-2020) 6.4.4 SWOT Analysis 6.5 GlaxoSmithKline 6.5.1 GlaxoSmithKline Company Profiles 6.5.2 GlaxoSmithKline Product Introduction 6.5.3 GlaxoSmithKline Monoclonal Antibody Therapeutics Production, Revenue (2015-2020) 6.5.4 SWOT Analysis 6.6 Merck 6.6.1 Merck Company Profiles 6.6.2 Merck Product Introduction 6.6.3 Merck Monoclonal Antibody Therapeutics Production, Revenue (2015-2020) 6.6.4 SWOT Analysis 6.7 Novartis 6.7.1 Novartis Company Profiles 6.7.2 Novartis Product Introduction 6.7.3 Novartis Monoclonal Antibody Therapeutics Production, Revenue (2015-2020) 6.7.4 SWOT Analysis 6.8 AbbVie 6.8.1 AbbVie Company Profiles 6.8.2 AbbVie Product Introduction 6.8.3 AbbVie Monoclonal Antibody Therapeutics Production, Revenue (2015-2020) 6.8.4 SWOT Analysis 6.9 Amgen 6.9.1 Amgen Company Profiles 6.9.2 Amgen Product Introduction 6.9.3 Amgen Monoclonal Antibody Therapeutics Production, Revenue (2015-2020) 6.9.4 SWOT Analysis 6.10 Johnson & Johnson 6.10.1 Johnson & Johnson Company Profiles 6.10.2 Johnson & Johnson Product Introduction 6.10.3 Johnson & Johnson Monoclonal Antibody Therapeutics Production, Revenue (2015-2020) 6.10.4 SWOT Analysis 6.11 Bristol-Myers Squibb Company 6.12 Biogen 7 Conclusion
List of Tables and Figures Figure Product Introduction Table Production (K Units) and Revenue (Million USD) of Major Players (2015-2020) Figure Global Monoclonal Antibody Therapeutics Production Market Share of Top 5 Players Table CAGR of Major Market (2021-2026) Table CAGR in Terms of Production of Each Type (2015-2026) Table CAGR in Terms of Production of Each Application (2015-2026) Table Global Monoclonal Antibody Therapeutics Sales (K Unit) by Type (2015-2026) Figure Global Monoclonal Antibody Therapeutics Sales (K Unit) and Growth Rate (2015-2026) Figure Global Monoclonal Antibody Therapeutics Sales Market Share (%) by Type (2019 -2020) Table Global Monoclonal Antibody Therapeutics Sales Value (Million USD) by Type (2015-2026) Figure Global Monoclonal Antibody Therapeutics Sales Value (Million USD) and Growth Rate (2015-2026) Figure Global Monoclonal Antibody Therapeutics Sales Value Market Share (%) by Type (2019-2020) Table Global Monoclonal Antibody Therapeutics Sales (K Unit) by Application (2015-2026) Table China Monoclonal Antibody Therapeutics Sales (K Unit) of Major Company (2015-2020) Table China Monoclonal Antibody Therapeutics Sales Market Share of Major Company (2015-2020) Table China Monoclonal Antibody Therapeutics Sales Value (Million USD) of Major Company (2015-2020) Figure China Monoclonal Antibody Therapeutics Sales Value (Million USD) and Growth Rate (2015-2020) Table China Monoclonal Antibody Therapeutics Sales Value Share of Major Company (2015-2020) Table China Monoclonal Antibody Therapeutics Price (USD/Unit), by Type (2019-2020) Table China Monoclonal Antibody Therapeutics Sales (Unit) by Type (2015-2026) Figure China Monoclonal Antibody Therapeutics Sales (Unit) by Type (2015-2026) Table EU Monoclonal Antibody Therapeutics Sales (K Unit) of Major Company (2015-2020) Table EU Monoclonal Antibody Therapeutics Sales Market Share of Major Company (2015-2020) Table EU Monoclonal Antibody Therapeutics Sales Value (Million USD) of Major Company (2015-2020) Figure EU Monoclonal Antibody Therapeutics Sales Value (Million USD) and Growth Rate (2015-2020) Table EU Monoclonal Antibody Therapeutics Sales Value Share of Major Company (2015-2020) Table EU Monoclonal Antibody Therapeutics Price (USD/Unit), by Type (2019-2020) Table EU Monoclonal Antibody Therapeutics Sales (Unit) by Type (2015-2026) Figure EU Monoclonal Antibody Therapeutics Sales (Unit) by Type (2015-2026) Table USA Monoclonal Antibody Therapeutics Sales (K Unit) of Major Company (2015-2020) Table USA Monoclonal Antibody Therapeutics Sales Market Share of Major Company (2015-2020) Table USA Monoclonal Antibody Therapeutics Sales Value (Million USD) of Major Company (2015-2020) Figure USA Monoclonal Antibody Therapeutics Sales Value (Million USD) and Growth Rate (2015-2020) Table USA Monoclonal Antibody Therapeutics Sales Value Share of Major Company (2015-2020) Table USA Monoclonal Antibody Therapeutics Price (USD/Unit), by Type (2019-2020) Table USA Monoclonal Antibody Therapeutics Sales (Unit) by Type (2015-2026) Figure USA Monoclonal Antibody Therapeutics Sales (Unit) by Type (2015-2026) Table Japan Monoclonal Antibody Therapeutics Sales (K Unit) of Major Company (2015-2020) Table Japan Monoclonal Antibody Therapeutics Sales Market Share of Major Company (2015-2020) Table Japan Monoclonal Antibody Therapeutics Sales Value (Million USD) of Major Company (2015-2020) Figure Japan Monoclonal Antibody Therapeutics Sales Value (Million USD) and Growth Rate (2015-2020) Table Japan Monoclonal Antibody Therapeutics Sales Value Share of Major Company (2015-2020) Table Japan Monoclonal Antibody Therapeutics Price (USD/Unit), by Type (2019-2020) Table Japan Monoclonal Antibody Therapeutics Sales (Unit) by Type (2015-2026) Figure Japan Monoclonal Antibody Therapeutics Sales (Unit) by Type (2015-2026) Table India Monoclonal Antibody Therapeutics Sales (K Unit) of Major Company (2015-2020) Table India Monoclonal Antibody Therapeutics Sales Market Share of Major Company (2015-2020) Table India Monoclonal Antibody Therapeutics Sales Value (Million USD) of Major Company (2015-2020) Figure India Monoclonal Antibody Therapeutics Sales Value (Million USD) and Growth Rate (2015-2020) Table India Monoclonal Antibody Therapeutics Sales Value Share of Major Company (2015-2020) Table India Monoclonal Antibody Therapeutics Price (USD/Unit), by Type (2019-2020) Table India Monoclonal Antibody Therapeutics Sales (Unit) by Type (2015-2026) Figure India Monoclonal Antibody Therapeutics Sales (Unit) by Type (2015-2026) Table Southeast Asia Monoclonal Antibody Therapeutics Sales (K Unit) of Major Company (2015-2020) Table Southeast Asia Monoclonal Antibody Therapeutics Sales Market Share of Major Company (2015-2020) Table Southeast Asia Monoclonal Antibody Therapeutics Sales Value (Million USD) of Major Company (2015-2020) Figure Southeast Asia Monoclonal Antibody Therapeutics Sales Value (Million USD) and Growth Rate (2015-2020) Table Southeast Asia Monoclonal Antibody Therapeutics Sales Value Share of Major Company (2015-2020) Table Southeast Asia Monoclonal Antibody Therapeutics Price (USD/Unit), by Type (2019-2020) Table Southeast Asia Monoclonal Antibody Therapeutics Sales (Unit) by Type (2015-2026) Figure Southeast Asia Monoclonal Antibody Therapeutics Sales (Unit) by Type (2015-2026) Table South America Monoclonal Antibody Therapeutics Sales (K Unit) of Major Company (2015-2020) Table South America Monoclonal Antibody Therapeutics Sales Market Share of Major Company (2015-2020) Table South America Monoclonal Antibody Therapeutics Sales Value (Million USD) of Major Company (2015-2020) Figure South America Monoclonal Antibody Therapeutics Sales Value (Million USD) and Growth Rate (2015-2020) Table South America Monoclonal Antibody Therapeutics Sales Value Share of Major Company (2015-2020) Table South America Monoclonal Antibody Therapeutics Price (USD/Unit), by Type (2019-2020) Table South America Monoclonal Antibody Therapeutics Sales (Unit) by Type (2015-2026) Figure South America Monoclonal Antibody Therapeutics Sales (Unit) by Type (2015-2026) Figure Value Chain Structure of Monoclonal Antibody Therapeutics Table Value Chain Table Key Suppliers of Raw Material/Components Table Key Downstream Customer in Each Application Field Table Industry News List of Monoclonal Antibody Therapeutics Figure Cost Structure of Monoclonal Antibody Therapeutics in 2020 Table Distributors/Traders List Table Regional Market Sales (K Unit) (2021-2026) Table Regional Market Sales Share (2021-2026) Figure Global Monoclonal Antibody Therapeutics Sales (Unit), Growth Rate & Market Share (2021-2026) Table Regional Market Sales Value (Million USD) (2021-2026) Table Regional Market Sales Value Share (2021-2026) Figure Global Monoclonal Antibody Therapeutics Sales Value (Million USD), Growth Rate & Market Share (2021-2026) Table ????Bayer Profiles Table ????Bayer Monoclonal Antibody Therapeutics Product Introduction Table ????Bayer Monoclonal Antibody Therapeutics Sales (Unit), Sales Value (Million USD), Price (USD/Unit) and Gross Profit (2015-2020) Figure ????Bayer SWOT Analysis Table ????F. Hoffmann-La Roche Profiles Table ????F. Hoffmann-La Roche Monoclonal Antibody Therapeutics Product Introduction Table ????F. Hoffmann-La Roche Monoclonal Antibody Therapeutics Sales (Unit), Sales Value (Million USD), Price (USD/Unit) and Gross Profit (2015-2020) Figure ????F. Hoffmann-La Roche SWOT Analysis Table ????Pfizer Profiles Table ????Pfizer Monoclonal Antibody Therapeutics Product Introduction Table ????Pfizer Monoclonal Antibody Therapeutics Sales (Unit), Sales Value (Million USD), Price (USD/Unit) and Gross Profit (2015-2020) Figure ????Pfizer SWOT Analysis Table ????Sanofi Profiles Table ????Sanofi Monoclonal Antibody Therapeutics Product Introduction Table ????Sanofi Monoclonal Antibody Therapeutics Sales (Unit), Sales Value (Million USD), Price (USD/Unit) and Gross Profit (2015-2020) Figure ????Sanofi SWOT Analysis Table ????GlaxoSmithKline Profiles Table ????GlaxoSmithKline Monoclonal Antibody Therapeutics Product Introduction Table ????GlaxoSmithKline Monoclonal Antibody Therapeutics Sales (Unit), Sales Value (Million USD), Price (USD/Unit) and Gross Profit (2015-2020) Figure ????GlaxoSmithKline SWOT Analysis Table ????Merck Profiles Table ????Merck Monoclonal Antibody Therapeutics Product Introduction Table ????Merck Monoclonal Antibody Therapeutics Sales (Unit), Sales Value (Million USD), Price (USD/Unit) and Gross Profit (2015-2020) Figure ????Merck SWOT Analysis Table ????Novartis Profiles Table ????Novartis Monoclonal Antibody Therapeutics Product Introduction Table ????Novartis Monoclonal Antibody Therapeutics Sales (Unit), Sales Value (Million USD), Price (USD/Unit) and Gross Profit (2015-2020) Figure ????Novartis SWOT Analysis Table ????AbbVie Profiles Table ????AbbVie Monoclonal Antibody Therapeutics Product Introduction Table ????AbbVie Monoclonal Antibody Therapeutics Sales (Unit), Sales Value (Million USD), Price (USD/Unit) and Gross Profit (2015-2020) Figure ????AbbVie SWOT Analysis Table ????Amgen Profiles Table ????Amgen Monoclonal Antibody Therapeutics Product Introduction Table ????Amgen Monoclonal Antibody Therapeutics Sales (Unit), Sales Value (Million USD), Price (USD/Unit) and Gross Profit (2015-2020) Figure ????Amgen SWOT Analysis Table ????Johnson & Johnson Profiles Table ????Johnson & Johnson Monoclonal Antibody Therapeutics Product Introduction Table ????Johnson & Johnson Monoclonal Antibody Therapeutics Sales (Unit), Sales Value (Million USD), Price (USD/Unit) and Gross Profit (2015-2020) Figure ????Johnson & Johnson SWOT Analysis Table ????Bristol-Myers Squibb Company Profiles Table ????Bristol-Myers Squibb Company Monoclonal Antibody Therapeutics Product Introduction Table ????Bristol-Myers Squibb Company Monoclonal Antibody Therapeutics Sales (Unit), Sales Value (Million USD), Price (USD/Unit) and Gross Profit (2015-2020) Figure ????Bristol-Myers Squibb Company SWOT Analysis Table ????Biogen Profiles Table ????Biogen Monoclonal Antibody Therapeutics Product Introduction Table ????Biogen Monoclonal Antibody Therapeutics Sales (Unit), Sales Value (Million USD), Price (USD/Unit) and Gross Profit (2015-2020)
